English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  52899575    ???header.onlineuser??? :  1007
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"szu chun"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 11-20 of 30  (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2022-11 PM2.5 exposure and risk of lung adenocarcinoma in women of Taiwan: A case-control study with density sampling Yang;Szu-Chun;Lin;Fang-Yu;Wu;Tzu-;I;Wu;Chih-Da;Wang;Jung-Der
國立成功大學 2022-11 Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio Tsai;Jeng-Shiuan;Wei;Sheng-Huan;Chen;Chian-Wei;Yang;Szu-Chun;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2022-05-21 Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program Kuo;Chin-Wei;Chen;Chuan-Yu;Wu;Chih-Hsing;Chen;Chang-Wen;Guo;Fei-Ran;Yang;Szu-Chun
國立成功大學 2022-05-20 Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naive Metastatic Lung Adenocarcinoma Yang;Szu-Chun;Lin;Chien-Chung;Chen;Yi-Lin;Su;Wu-Chou
國立成功大學 2022-03-14 Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study Kuo;Chin-Wei;Yang;Szu-Chun;Shih;Yu-Fen;Liao;Xin-Min;Lin;Sheng-Hsiang
國立成功大學 2022-02-28 The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy Su;Po-Lan;Chen;Jung-Yueh;Chu;Chang-Yao;Chen;Yi-Lin;Chen;Wan-Li;Lin;Kuan-Yu;Ho;Chung-Liang;Tsai;Jeng-Shiuan;Yang;Szu-Chun;Chen;Chian-Wei;Wu;Yi-Lin;Tseng;Yau-Lin;Chang;Chao-Chun;Yen;Yi-Ting;Lin;Chia-Ying;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2022-01 Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors Wang;Sheng-Yuan;Lai;Ching-Han;Chen;Chian-Wei;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Su;Po-Lan;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2021-12 QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon Lai;Wu-Wei;Chung;Chia-Hua;Lin;Chia-Ni;Yang;Szu-Chun;Hwang;Jing-Shiang;Wang;Jung-Der
國立成功大學 2021-09 EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis Tsai;Jeng-Shiuan;Su;Po-Lan;Yang;Szu-Chun;Chang;Chao-Chun;Lin;Chia-Ying;Yen;Yi-Ting;Tseng;Yau-Lin;Lai;Wu-Wei;Lin;Chien-Chung;Su;Wu-Chou
國立成功大學 2021-06-9 Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data Yang;Szu-Chun;Wang;Jung-Der;Wang;Shi-Yi

Showing items 11-20 of 30  (3 Page(s) Totally)
<< < 1 2 3 > >>
View [10|25|50] records per page